• phone 1-855-475-7782 | fax 1-855-475-7787
 

global pharmacy plus review
shop secure
 newsletter

Tarceva (Erlotinib) - 150mg, 30 Tabs

Product Details

Non-Small Cell Lung Cancer

TARCEVA monotherapy is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of at least one prior chemotherapy regimen.



Results from two, multicenter, placebo-controlled, randomized, Phase 3 trials conducted in first-line patients with locally advanced or metastatic NSCLC showed no clinical benefit with the concurrent administration of TARCEVA with platinum-based chemotherapy [carboplatin and paclitaxel or gemcitabine and cisplatin] and its use is not recommended in that setting.



Pancreatic Cancer

TARCEVA in combination with gemcitabine is indicated for the first-line treatment of patients with locally advanced, unresectable or metastatic pancreatic cancer.

  • Quanity:30 Tabs
  • Strength: 150mg
Our Generic Price:
$1750.00

Availability: In stock

$1,750.00

There are no products matching the selection.

1,750.00 In stock